Increased microRNA-630 expression in gastric cancer is associated with poor overall survival.
about
Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric CancerComparison of Prognostic MicroRNA Biomarkers in Blood and Tissues for Gastric CancerRecent advances in the molecular diagnostics of gastric cancerDecreased miR-204 in H. pylori-associated gastric cancer promotes cancer cell proliferation and invasion by targeting SOX4.Up-regulation of miR-630 in clear cell renal cell carcinoma is associated with lower overall survival.Down-regulation of miR-497 is associated with poor prognosis in renal cancer.miR-630 overexpression in hepatocellular carcinoma tissues is positively correlated with alpha-fetoprotein.Single-nucleotide polymorphisms of microRNA processing machinery genes are associated with risk for gastric cancer.Downregulation of rho-associated protein kinase 1 by miR-124 in colorectal cancer.Characterization of CLL exosomes reveals a distinct microRNA signature and enhanced secretion by activation of BCR signalingMicroRNAs: an emerging player in autophagy.MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinomaIdentification of miRNA-mRNA crosstalk in CD4+ T cells during HIV-1 infection by integrating transcriptome analyses.Primary and recurrent ovarian high-grade serous carcinomas display similar microRNA expression patterns relative to those of normal ovarian tissuemiR-630 functions as a tumor oncogene in renal cell carcinomaMiR-374a promotes the proliferation of osteosarcoma cell proliferation by targeting Axin2.Inhibition of miR-630 enhances the cell resistance to radiation by directly targeting CDC14A in human gliomamiR-630 targets LMO3 to regulate cell growth and metastasis in lung cancer.Prognostic value of microRNAs in gastric cancer: a meta-analysisDysregulation of miR-126/Crk protein axis predicts poor prognosis in gastric cancer patients.Expression of miRNA-630 in bladder urothelial carcinoma and its clinical significance.A low microRNA-630 expression confers resistance to tyrosine kinase inhibitors in EGFR-mutated lung adenocarcinomas via miR-630/YAP1/ERK feedback loop.MicroRNA-630 may confer favorable cisplatin-based chemotherapy and clinical outcomes in non-small cell lung cancer by targeting Bcl-2.
P2860
Q26744362-ECC5ABA9-6A8C-485A-8FEE-307F3F20DCC9Q26771422-8BB06D23-20A5-4C49-AB0E-20C9C50658F1Q26785548-D06479C4-DD44-4027-B65E-A961343DB58AQ33831182-B937AA58-A8DA-4B11-964F-9243FA75E8CDQ33898533-8514A5C2-0B1E-40BA-9713-585E20411108Q35145299-61657CE6-77DD-40E4-9172-9EC20D70F6ECQ35167131-D89EACD4-F8CC-45F0-8B55-9B78B15FE4AAQ35168697-FBBEACDD-6035-4D6E-A6CD-B036D8521377Q35594181-E71CDAD7-C65F-4827-A52D-B4A76D41C192Q35634885-FF0BC093-5CC3-46B0-A6A9-C65CF1F0D164Q36429332-26A4AA29-693D-4746-958E-8B113E3D72A4Q37225640-50E7B687-D74D-4474-9E21-21EDCC7250DEQ37655340-705164DB-44F5-4E14-9828-D2460A630DA9Q37688565-C0265C53-C1C7-4732-A7E1-19BB90A998B2Q38765549-0477D2CB-898B-4E27-BB14-7BDB801EBC68Q38815853-EA7B4409-F03D-4349-A8B7-8ADD0AD1FA61Q38848860-7FA1F057-CCE4-4D4C-8550-F77594781153Q38968611-A66F915C-9797-4562-B584-71AB176326F1Q41548169-19DF7080-7569-4F83-AE34-A0CE516B58FCQ47368202-86C7E9E7-E2D8-43FA-B228-AA32AAB8305CQ51766901-741C6948-FCB9-42DD-BDCE-CDE63042A7E9Q54939484-E2F0EA56-8A87-4CCD-B302-1A1C85097EECQ55410765-4EF7058F-8E84-45D5-9F02-63666BC2B83A
P2860
Increased microRNA-630 expression in gastric cancer is associated with poor overall survival.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Increased microRNA-630 express ...... ed with poor overall survival.
@ast
Increased microRNA-630 express ...... ed with poor overall survival.
@en
type
label
Increased microRNA-630 express ...... ed with poor overall survival.
@ast
Increased microRNA-630 express ...... ed with poor overall survival.
@en
prefLabel
Increased microRNA-630 express ...... ed with poor overall survival.
@ast
Increased microRNA-630 express ...... ed with poor overall survival.
@en
P2093
P2860
P1433
P1476
Increased microRNA-630 express ...... ed with poor overall survival.
@en
P2093
Jianyong Zheng
Qingchuan Zhao
Weizhong Wang
Yunming Li
Zhengwei Zhao
P2860
P304
P356
10.1371/JOURNAL.PONE.0090526
P407
P577
2014-03-12T00:00:00Z